If you liked this article you might like

These 5 Stocks Are Breaking Out This Summer
16 Biopharma Companies Besides Medivation That Are Attractive Targets
Ultragenyx Pharmaceutical (RARE) Stock Gets 'Outperform' Rating at Leerink
Battleground: Will This $5 Biotech Stock Go To $22 Or $1.50?